3 ETFs With PLTR Exposure To Consider As Nasdaq-100 Rebalance Looms
Palantir Technologies Inc. PLTR is making a big move from the NYSE to the Nasdaq Global Select Market, effective Nov. 26.
Could this be a step toward a future inclusion in the Nasdaq-100 Index?
Investors are now watching the stock’s exposure in exchange-traded funds (ETFs),
» Read more about: 3 ETFs With PLTR Exposure To Consider As Nasdaq-100 Rebalance Looms »
Read More3 Unstoppable Growth Stocks to Buy if There's a Stock Market Sell-Off
It’s no secret that the major market indices have been hitting new highs. Investors feel optimistic over the recently concluded presidential election amid news of a healthy economy.
However, unexpected bad news could trigger a sharp and sudden sell-off. Investors need to understand that such sell-offs are normal in the stock market. Rather than feeling surprised,
» Read more about: 3 Unstoppable Growth Stocks to Buy if There's a Stock Market Sell-Off »
Read MoreStock market today: Indexes rise and dollar gains as stock investors head for a winning week
Advertisement
- US stocks were up on Friday as the market headed for a weekly gain.
- The US dollar, meanwhile, surged to its highest since November 2022.
- Earnings season has nearly concluded with 77% of S&P 500 firms beating third-quarter profit estimates.
Stock market today: Wall Street opens higher as it heads for a winning week
NEW YORK (AP) — Stocks edged higher in midday trading on Wall Street Friday, keeping the market on track for its fifth gain in a row.
The S&P 500 was up 0.1% and is solidly on track for a weekly gain that will erase most of last week’s loss.
The Dow Jones Industrial Average climbed 226 points,
» Read more about: Stock market today: Wall Street opens higher as it heads for a winning week »
Read MoreStock market today: Dow, S&P 500 jump after Nvidia earnings, while Alphabet tumbles
The Burst
Will This Silicon Valley Darling Topple The Market?
Silicon Valley darling, Salesforce, saw its stock fall 16% following last night’s fiscal Q1 2025 earnings report. Growth moderated to an 11% year-over-year increase, which was the lower end of the guidance and that was enough to spook investors.
Yet the woes continued when full-year revenue guidance of $37.7 billion to $38 billion was reported because it reflected a growth projection of just 8% to 9%.
» Read more about: Will This Silicon Valley Darling Topple The Market? »
Read MoreThe Ivy
Golden Cross Gives Bulls Green Light?
One of the more unexpected tailwinds for healthcare stocks in recent years has been the weight-loss frenzy brought about most notably by Ozempic.
Novo Nordisk’s drug was such a hit that the share price soared by 62% over the past year alone. Yet it’s not the only game in town. Eli Lilly’s weight-loss drug,
» Read more about: Golden Cross Gives Bulls Green Light? »
Read MoreThe Spotlight
Spotlight: AI + Robotics = 4x Growth
Google. Apple. Amazon. Microsoft. They are all investing in AI but one company you probably have not heard about is Symbiotic, a warehousing automation firm that combines advanced robotics with artificial intelligence.
It’s one of those businesses that’s hard to wrap your head around at first but it’s been a huge hit on Wall Street.